In July 2025, 135 employees from across Russia took part in the first-ever corporate sports camp EgiSport — a 21-day online marathon created by employees, for employees. With no external contractors and full creative freedom, the project became more than just a fitness initiative — it turned into a true celebration of corporate culture and team spirit.

The Russian market of anticoagulants has been expanded with European rivaroxan produced by Egis Pharmaceuticals PLC (Hungary). The product from the class of direct oral anticoagulants combines European manufacturing standards and practical benefits for patients. With a convenient one-pill-per-day regime and affordability, this product opens up new possibilities in the prevention of thrombosis, significantly increasing the availability of modern anticoagulation therapy and contributing to improved patient commitment to long-term treatment.

Egis Pharmaceuticals Plc. applied for the prestigious Top Employer Hungary certification for the first time and successfully joined the ranks of companies recognized for their outstanding employer practices on an international level.